Tycho Peterson
Stock Analyst at Jefferies
(5.00)
# 3
Out of 5,149 analysts
139
Total ratings
67.35%
Success rate
154.82%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DGX Quest Diagnostics | Maintains: Buy | $215 → $220 | $208.36 | +5.59% | 4 | Feb 11, 2026 | |
| RVTY Revvity | Maintains: Hold | $100 → $105 | $95.95 | +9.43% | 2 | Feb 3, 2026 | |
| DHR Danaher | Maintains: Overweight | $270 → $275 | $204.01 | +34.80% | 5 | Jan 29, 2026 | |
| AVTR Avantor | Downgrades: Underperform | $12 → $9 | $8.78 | +2.51% | 1 | Dec 17, 2025 | |
| BLLN BillionToOne | Initiates: Hold | $117 | $83.14 | +40.73% | 1 | Dec 1, 2025 | |
| WAT Waters | Maintains: Buy | $435 → $385 | $312.14 | +23.34% | 8 | Aug 4, 2025 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $155 | $119.04 | +30.21% | 8 | May 29, 2025 | |
| WGS GeneDx Holdings | Upgrades: Buy | $80 | $76.97 | +3.94% | 1 | May 9, 2025 | |
| QDEL QuidelOrtho | Upgrades: Buy | $44 | $21.48 | +104.84% | 6 | May 8, 2025 | |
| MTD Mettler-Toledo International | Upgrades: Hold | $1,200 → $1,100 | $1,316.71 | -16.46% | 8 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $275 → $290 | $282.99 | +2.48% | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $9.54 | +130.61% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $85 | $75.46 | +12.64% | 7 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $41 → $53 | $47.65 | +11.16% | 5 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $35 | $46.65 | -24.97% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $22.62 | +6.10% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.52 | +163.16% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $2.41 | +24.48% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $207.04 | -31.41% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $93.30 | -65.70% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $129.56 | -11.24% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $5.29 | +278.07% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $508.10 | +27.93% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $15.70 | -42.68% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.24 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $1.80 | +566.67% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $5.87 | +922.15% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $4.10 | +460.98% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $175.69 | +121.98% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $2.98 | +504.03% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $497.42 | -59.79% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $28.67 | -16.29% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $13.30 | +238.35% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $123.06 | -43.12% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $173.96 | -31.02% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $0.53 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $39.27 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $8.16 | +574.02% | 1 | Jul 19, 2016 |
Quest Diagnostics
Feb 11, 2026
Maintains: Buy
Price Target: $215 → $220
Current: $208.36
Upside: +5.59%
Revvity
Feb 3, 2026
Maintains: Hold
Price Target: $100 → $105
Current: $95.95
Upside: +9.43%
Danaher
Jan 29, 2026
Maintains: Overweight
Price Target: $270 → $275
Current: $204.01
Upside: +34.80%
Avantor
Dec 17, 2025
Downgrades: Underperform
Price Target: $12 → $9
Current: $8.78
Upside: +2.51%
BillionToOne
Dec 1, 2025
Initiates: Hold
Price Target: $117
Current: $83.14
Upside: +40.73%
Waters
Aug 4, 2025
Maintains: Buy
Price Target: $435 → $385
Current: $312.14
Upside: +23.34%
Agilent Technologies
May 29, 2025
Maintains: Overweight
Price Target: $160 → $155
Current: $119.04
Upside: +30.21%
GeneDx Holdings
May 9, 2025
Upgrades: Buy
Price Target: $80
Current: $76.97
Upside: +3.94%
QuidelOrtho
May 8, 2025
Upgrades: Buy
Price Target: $44
Current: $21.48
Upside: +104.84%
Mettler-Toledo International
May 5, 2025
Upgrades: Hold
Price Target: $1,200 → $1,100
Current: $1,316.71
Upside: -16.46%
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $282.99
Upside: +2.48%
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $9.54
Upside: +130.61%
Dec 10, 2024
Initiates: Hold
Price Target: $85
Current: $75.46
Upside: +12.64%
Dec 10, 2024
Assumes: Buy
Price Target: $41 → $53
Current: $47.65
Upside: +11.16%
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $46.65
Upside: -24.97%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $22.62
Upside: +6.10%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.52
Upside: +163.16%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $2.41
Upside: +24.48%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $207.04
Upside: -31.41%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $93.30
Upside: -65.70%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $129.56
Upside: -11.24%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $5.29
Upside: +278.07%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $508.10
Upside: +27.93%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $15.70
Upside: -42.68%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $4.24
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $1.80
Upside: +566.67%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $5.87
Upside: +922.15%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $4.10
Upside: +460.98%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $175.69
Upside: +121.98%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $2.98
Upside: +504.03%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $497.42
Upside: -59.79%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $28.67
Upside: -16.29%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $13.30
Upside: +238.35%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $123.06
Upside: -43.12%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $173.96
Upside: -31.02%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $0.53
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $39.27
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $8.16
Upside: +574.02%